回顾这款疫苗的获批历程,2020年12月18日,FDA授予Spikevax紧急使用授权(EUA),以预防由SARS-CoV-2引起的COVID-19。一年多后(2022年1月31日),该疫苗获FDA全面批准。 从时间线上看,无论是获得EUA的时间还是获FDA全面批准的时间,Moderna的Spikevax均稍微落后于辉瑞/BioNTech的Co...
“如果没有Mandl团队的工作,Moderna不可能成功开发其COVID-19疫苗。”在近日进行的诉讼案中,GSK如是表示。 2024年10月,GSK“一纸诉状”将凭借mRNA技术名声大噪的Moderna告上法庭,指控对方在其COVID-19mRNA疫苗——Spikevax(mRNA-1273)的开发中侵犯了GSK所拥有的mRNA疫苗相关开发技术,希望得到相应的赔偿。 这并不...
The reports should include the words “Moderna COVID- 19 Vaccine EUA” in the description section of the report. Click for Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) and Full EUA Prescribing Information for more information. Slide 3 Software uses a binary ...
“We are proud to share that we have initiated our EUA submission for authorization for our COVID-19 vaccine for young children,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We believe mRNA-1273 will be able to safely protect these...
The Moderna COVID-19 vaccine 2024-2025 Formula is an mRNA COVID-19 vaccine that may help your child develop immunity to SARS-CoV-2, the virus that causes COVID-19. The Moderna COVID-19 vaccine has been granted Emergency Use Authorization (EUA) for childr
Moderna asked the Food and Drug Administration for emergency authorization of a second booster of its COVID-19 vaccine for all adults.
Moderna's Spikevax is given as a series of two doses, one month apart, and can be used interchangeably with the EUA-approved vaccine to finish the vaccination series, the FDA said. "Our COVID-19 vaccine has been administered to hundreds of millions of people around the world, protecting ...
回顾这款疫苗的获批历程,2020年12月18日,FDA授予Spikevax紧急使用授权(EUA),以预防由SARS-CoV-2引起的COVID-19。一年多后(2022年1月31日),该疫苗获FDA全面批准。 从时间线上看,无论是获得EUA的时间还是获FDA全面批准的时间,Moderna的Spikevax均稍微落后于辉瑞/BioNTech的Co...
Please see theSPIKEVAX Full Prescribing Information. For information regarding authorized emergency uses of the Moderna COVID-19 Vaccine, please see theEUA Fact Sheet. Forward Looking Statements This press release contains forward-looking statements wi...